prescription glp-1 GLP-1s for Weight Loss Ease your GLP GLP-1 Weight Loss Drugs May

GLP1 receptor agonist use was shown to be associated with a reduction in the risk for progression to cirrhosis in patients with MASLD and diabetes, and who started the medication early in the course of their disease, 13 leading the FDA to approve semaglutide for this condition in August 2025

Despite participating in outpatient treatment and trialing naltrexone, her alcohol cravings remain severe

The analysis found that treatment with GLP-1RAs led to significant weight loss and improved glycaemic control in adults with mental illness taking psychotropics

Patient Safety and Liability Risks Incomplete patient evaluations, inadequate monitoring, and poor documentation can increase patient safety concerns

It increases the risk of: Type 2 diabetes Non-alcoholic fatty liver disease (NAFLD) Cardiovascular disease Simultaneously, the loss of estrogen accelerates sarcopenia , the loss of lean muscle mass, which further slows metabolism and reduces energy expenditure